H. Ward Wolff

2014

In 2014, H. Ward Wolff earned a total compensation of $1.7M as Executive Vice President and Chief Financial Officer at Sangamo Biosciences, a 4% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$145,800
Option Awards$607,343
Salary$405,000
Stock Awards$527,625
Total$1,685,768

Wolff received $607.3K in option awards, accounting for 36% of the total pay in 2014.

Wolff also received $145.8K in non-equity incentive plan, $405K in salary and $527.6K in stock awards.

Rankings

In 2014, H. Ward Wolff's compensation ranked 5,258th out of 13,032 executives tracked by ExecPay. In other words, Wolff earned more than 59.7% of executives.

ClassificationRankingPercentile
All
5,258
out of 13,032
60th
Division
Manufacturing
1,876
out of 4,965
62nd
Major group
Chemicals And Allied Products
630
out of 1,690
63rd
Industry group
Drugs
482
out of 1,369
65th
Industry
Biological Products, Except Diagnostic Substances
83
out of 241
66th
Source: SEC filing on April 25, 2017.

Wolff's colleagues

We found four more compensation records of executives who worked with H. Ward Wolff at Sangamo Biosciences in 2014.

2014

Edward Lanphier

Sangamo Biosciences

Chief Executive Officer

2014

Geoffrey Nichol

Sangamo Biosciences

Former Executive Vice President, Research and Development

2014

Philip Gregory

Sangamo Biosciences

Chief Scientific Officer

2014

Dale Ando

Sangamo Biosciences

Chief Medical Officer

You may also like